
Financials · Property & Casualty Insurance
$305.05
-0.03%
Vol: 674K
Friday, May 1, 2026
Travelers Q1 2026 core EPS $7.71 beat consensus $7.08, announced 14% dividend increase to $1.25 per share. Continues benefiting from favorable industry conditions, lower catastrophe losses, and pricing discipline. Stock +2.82% week, +3.09% month, +17.78% year. Recent analyst upgrades: BMO Capital raised PT to $314 from $297, Roth Capital to $345 from $320, Argus to $330 from $295, Keefe Bruyette to $342 from $340. Joined California's Sustainable Insurance Strategy to expand homeowners coverage with enhanced risk-based pricing.
Travelers reported Q1 2026 core EPS of $7.71, exceeding consensus of $7.08, and raised quarterly dividend 14% to $1.25 per share. Net income for Q4 2025 reached $2.496 billion ($11.06 per diluted share) versus $2.082 billion in prior year quarter. Company is expanding homeowners insurance offerings in California with strategic focus on risk-based pricing and wildfire mitigation. Recent insider activity on April 29 included Vice Chairman William Heyman selling 1,557 shares valued at $483,670. Analysts raised price targets: BMO Capital to $314 from $297, Roth Capital to $345 from $320, and Argus to $330 from $295. Stock gained 2.82% week-over-week with 17.78% one-year return.
Travelers Companies scheduled Q1 2026 earnings call for April 16 (today) with consensus estimates of 3.9% revenue increase to $12.34B and 258.1% EPS jump to $6.84. Company announced partnership with Anthropic to expand AI-enabled engineering and analytics capabilities. Q4 2025 showed strong results driven by disciplined underwriting and higher net investment income. $5B share repurchase program authorized (buyback 8.3% of outstanding shares). Market cap $63.81B; trading at $297.19 with P/E 10.78 and 1.5% dividend yield. Bank of America lowered target to $257; Barclays raised to $331. Consensus Hold with median target $257.
Travelers will release Q1 2026 results on April 16 with consensus estimates projecting EPS of $6.84 (+258.1% YoY) and revenue of $12.34B (+3.9%). Barclays raised price target to $331 from $312 on April 8. Evercore ISI reaffirmed Buy rating on April 10. Recent performance driven by disciplined underwriting and higher net investment income. Stock up 24.21% annual gain.
Travelers will report Q1 2026 earnings April 16 with consensus showing 258% EPS jump to $6.84 on 3.9% revenue growth to $12.34B. Keefe Bruyette raised target to $340; Raymond James to $330; Piper Sandler maintained $324; Barclays raised to $331. Strong Q4 driven by disciplined underwriting and higher net investment income.
Travelers Companies will report Q1 2026 results on April 16 with EPS expectations of $6.96 on $10.75B revenue. Barclays raised price target from $312 to $331 while maintaining Hold; Evercore ISI reaffirmed Buy. Company shows robust 45.2% annual EPS growth and 19.7% expected book value increase. Stock trading at $297.26.
The Travelers Companies reported Q4 2025 EPS of $11.13, crushing estimates of $8.61 by 29.27%, and announced a $5 billion share repurchase program. Travelers has beaten EPS estimates in 7 consecutive quarters. The company will release Q1 2026 results on April 16. Morgan Stanley raised price target to $310 from $295. Stock near $297.
The Travelers Companies (TRV) reached all-time high of $309.90, driven by strong Q4 earnings, disciplined underwriting, and higher net investment income. Company reported robust 45.2% annual EPS growth and 19.7% expected book value increase. Expanded share buyback authorization reflects confidence in financial health. Q4 net income of $1.9B (50% increase YoY). Insider selling activity noted amid volatile insurance market and maritime geopolitical tensions. Analyst estimates: max $340, min $259. Stock up 24.21% over past year, down 3.19% over past month. Operates Business Insurance, Bond & Specialty Insurance, and Personal Insurance segments.
Travelers Companies reported Q4 2025 EPS of $11.13, 27.35% above forecasts, with revenue of $12.43 billion. Core income grew 26% YoY to $2.5 billion. The company returned $1.9 billion to shareholders in Q4 including $1.7 billion in buybacks. Core return on equity reached 29.6% for Q4 and 19.4% for full year. 2026 guidance expects expense ratio of ~28.5%.
Travelers Companies reported strong Q4 driven by disciplined underwriting and higher net investment income. Board expanded $5B share repurchase authorization (8.3% of outstanding shares). Recent maritime insurance increases driven by geopolitical tensions. Stock at $294.54 up 1.19% past 24 hours, down 4.45% past month but up 14.51% YoY. Analysts divided on outlook with expectations for significant Q1 EPS rise. Company is DOW component with 30K+ employees and diverse global operations. Mixed insider trading signals complicate near-term thesis. Analyst estimates range $259-$340 per share.
Travelers completed sale of personal insurance and majority commercial insurance businesses in Canada to Definity Financial for ~$2.4B. Expected to deploy ~$700M net proceeds toward additional share repurchases in 2026. Transaction and buybacks expected slightly accretive to 2026+ EPS. Strong Q4 2025 results driven by disciplined underwriting and higher net investment income. Board authorized additional $5.0B share repurchase. Travelers and National Trust for Historic Preservation launched Travelers Across America yearlong initiative advancing community resilience. AI-driven initiatives to enhance claims processing and customer satisfaction. Announced 2026 Personal Insurance Agents of the Year honoring nine independent agents. Q1 2026 earnings call April 16. Stock down $1.82 after-hours at $291.82. Analyst consensus Buy though valuation reassessment underway.
Travelers Companies reported strong Q4 earnings driven by disciplined underwriting and higher net investment income. Company launched AI Claim Assistant using OpenAI capabilities. Board expanded share buyback authorization. Keefe Bruyette raised target to $340 from $320; Piper Sandler maintains Buy. Morgan Stanley maintains Sell rating.
Travelers reports strong Q4 2025 earnings with non-GAAP core EPS of $11.13 vs $8.89 consensus (22% beat); introduces AI-driven claims initiatives.
Travelers will report Q1 2026 results on April 16 at 9:30 a.m. ET. Strong Q4 2025 driven by disciplined underwriting and higher net investment income. Morgan Stanley raised PT to $310 from $295 with Equal Weight rating.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| CBCHUBB | $326.61 | -0.12% | +0.0% | 11.2x | 0.50 | $126.8B |
| PGRPROGRESSIVE | $199.87 | -0.70% | +2.5% | 12.5x | 0.33 | $117.6B |
| TRVTRAVELERS | $305.05 | -0.03% | +3.2% | 10.7x | 0.52 | $64.9B |
| ALLALLSTATE | $217.11 | -0.07% | +4.3% | 8.4x | 0.22 | $56.1B |
| HIGHARTFORD | $136.06 | -0.55% | +0.3% | 9.5x | 0.53 | $37.5B |
| ACGLARCH | $93.92 | -0.57% | -2.4% | 9.4x | 0.38 | $33.4B |
Price above both MAs — bullish structure.